Read More 3 minute read Pharma Industry News Xencor stock skyrockets 26% overnight after breakthrough in cancer research Xencor, Inc., a clinical-stage biopharmaceutical company specializing in engineered antibodies for cancer treatment, saw its stock rise by… byPallavi MadhirajuSeptember 9, 2024